Clinical Trials Logo

Mineralocorticoid Excess clinical trials

View clinical trials related to Mineralocorticoid Excess.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05925569 Not yet recruiting - Hypertension Clinical Trials

Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension

ALERT-PA
Start date: December 2023
Phase: N/A
Study type: Interventional

Primary aldosteronism (PA) is common but rarely recognized cause of hypertension that carries excess cardiovascular and renal risk and has approved targeted treatments. Despite current clinical guidelines that recommend screening in a defined set of high-risk populations, less than 5% of eligible patients are ever screened for PA. This study aims to evaluate the impact of a computer decision support Best Practice Advisory (BPA) alert on rates of screening for PA in guideline-eligible patients, referral to specialist PA care, and treatment with mineralocorticoid receptor antagonists.

NCT ID: NCT04439708 Not yet recruiting - Clinical trials for Choroidal Neovascularization

Biomarkers and Choroidal Neovascularization

BioNéoRet
Start date: June 15, 2020
Phase:
Study type: Observational

The aim of the study is to find biomarkers in the blood and aqueous humor of patients with type 1 choroidal neovascularization and correlate them with the response to anti-VEGF treatment.